- Home
- ILAG vs LGVN Comparison
ILAG vs LGVN Comparison
Compare ILAG & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILAG
- LGVN
- Stock Information
- Founded
- ILAG 1981
- LGVN 2014
- Country
- ILAG Hong Kong
- LGVN United States
- Employees
- ILAG N/A
- LGVN N/A
- Industry
- ILAG Office Equipment/Supplies/Services
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- ILAG Consumer Discretionary
- LGVN Health Care
- Exchange
- ILAG Nasdaq
- LGVN Nasdaq
- Market Cap
- ILAG 11.1M
- LGVN 16.4M
- IPO Year
- ILAG 2022
- LGVN 2021
- Fundamental
- Price
- ILAG $0.65
- LGVN $0.79
- Analyst Decision
- ILAG
- LGVN Strong Buy
- Analyst Count
- ILAG 0
- LGVN 2
- Target Price
- ILAG N/A
- LGVN $6.50
- AVG Volume (30 Days)
- ILAG 717.6K
- LGVN 496.8K
- Earning Date
- ILAG 04-28-2025
- LGVN 11-11-2025
- Dividend Yield
- ILAG N/A
- LGVN N/A
- EPS Growth
- ILAG N/A
- LGVN N/A
- EPS
- ILAG N/A
- LGVN N/A
- Revenue
- ILAG $7,506,551.00
- LGVN $2,073,000.00
- Revenue This Year
- ILAG N/A
- LGVN N/A
- Revenue Next Year
- ILAG N/A
- LGVN N/A
- P/E Ratio
- ILAG N/A
- LGVN N/A
- Revenue Growth
- ILAG 16.50
- LGVN 68.67
- 52 Week Low
- ILAG $0.34
- LGVN $0.63
- 52 Week High
- ILAG $1.21
- LGVN $2.48
- Technical
- Relative Strength Index (RSI)
- ILAG 56.76
- LGVN 37.95
- Support Level
- ILAG $0.47
- LGVN $0.78
- Resistance Level
- ILAG $0.96
- LGVN $0.85
- Average True Range (ATR)
- ILAG 0.09
- LGVN 0.05
- MACD
- ILAG 0.02
- LGVN 0.02
- Stochastic Oscillator
- ILAG 37.16
- LGVN 46.30
About ILAG Intelligent Living Application Group Inc.
Intelligent Living Application Group Inc focuses on designing and producing affordable, high-quality locksets and smart security systems. The company offers high-quality mechanical locksets and smart locks to its customers. Its product portfolio comprises various ODM indoor and outdoor locksets, such as deadbolts, entry locksets, privacy locksets, passage locksets, and storeroom locks, which are marketed through brands like Kambo and Bamberg. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.